Quarterly report pursuant to Section 13 or 15(d)

Earnings (Loss) Per Share (Tables)

v3.22.2.2
Earnings (Loss) Per Share (Tables)
9 Months Ended
Sep. 30, 2022
Earnings Per Share [Abstract]  
Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share
The following table presents the potentially dilutive shares that were excluded from the computation of diluted net loss per share of common stock, because their effect was anti-dilutive:

Three Months Ended September 30, Nine Months Ended September 30,
2022 2021 2022 2021
Stock-based awards and warrants 3,364,289  3,987,285  10,129,870  3,987,285 
Convertible notes(1)
—  —  7,833,666  — 

(1) Represents shares issued in exchange of convertible notes in April 2022. See Note 6, Debt, for additional information regarding shares issued subsequent to the date of the Condensed Consolidated Financial Statements.